Exopharm (ASX:EX1) Shares Down 3.4%

Share on StockTwits

Exopharm Limited (ASX:EX1)’s share price dropped 3.4% during mid-day trading on Friday . The stock traded as low as A$0.28 ($0.20) and last traded at A$0.28 ($0.20), approximately 79,820 shares traded hands during trading. The stock had previously closed at A$0.29 ($0.21).

The company has a fifty day simple moving average of A$0.36. The firm has a market capitalization of $26.73 million and a PE ratio of -7.00.

About Exopharm (ASX:EX1)

Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing clinical human therapeutics in Australia. It is developing Plexaris, an exosome derived from human platelets; and Exomeres, an exosome derived from adult stem cells. The company was founded in 2003 and is headquartered in Melbourne, Australia.

Further Reading: How analysts view the yield curve

Receive News & Ratings for Exopharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exopharm and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.